-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: Myriad Case
Recent Developments in Patentability: Prometheus and Myriad
By Joe Allen, President, Allen and Associates Recent Developments in Patentability: Prometheus and Myriad at the 2012 BIO International Convention was a very lively panel discussion on two cases that have set the life science industry on edge. The discussion presented an appropriate diversity of views as experts struggle with how broadly these cases should be interpreted. Briefly, the unanimous decision by the Supreme Court overtuning a decision upholding the Prometheus patents by the Court Read More >
Biotech Patenting and Tech Transfer at 2011 BIO International Convention
The Biotech Patenting and Tech Transfer track has a lot to offer 2011 BIO International Convention Attendees. High level speakers include White House Intellectual Property Enforcement Coordinator Victoria Espinel, European Patent Office Director of Biotechnology Sjoerd Hoekstra, retired Chief Judge of the U.S. Court of Appeals for the Federal Circuit Paul Michel, and former Solicitors General Seth Waxman and Paul Clement to name a few. I am particularly excited about the breadth of the Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: 2011 BIO International Convention, BIO, biosimilars, Biotech Patenting, collaboration, Collaborative R&D, Compulsory Licensing, Counterfeiting, EPO, Myriad Case, Patent Linkage, Patents in the Supreme Court, Paul Clement, Paul Michel, Seth Waxman, Sjoerd Hoekstra, Tech Transfer, Technology Transfer, Victoria Espinel
Tags: 2011 BIO International Convention, BIO, biosimilars, Biotech Patenting, collaboration, Collaborative R&D, Compulsory Licensing, Counterfeiting, EPO, Myriad Case, Patent Linkage, Patents in the Supreme Court, Paul Clement, Paul Michel, Seth Waxman, Sjoerd Hoekstra, Tech Transfer, Technology Transfer, Victoria Espinel
IP Position Critical to Biotech Investment
A great article from Genetic Engineering and Biotechnology News written by Lisa Haile reviewing the Myriad case and its implications for future medical advances. Interesting Quotes: “While it is unfortunate, I have seen quite a few technologies over the years that would be of potential great benefit to patients, but the intellectual property was simply not there to support protecting the product from fast followers in the market place,” explains Robert More, a general partner Read More >
